|
|
Volumn 137, Issue 4, 2016, Pages 1258-1261.e10
|
|
Safety of epicutaneous immunotherapy for the treatment of peanut allergy: A phase 1 study using the Viaskin patch
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ADRENALIN;
ANTIHISTAMINIC AGENT;
HYDROCORTISONE;
IMMUNOGLOBULIN E ANTIBODY;
PLACEBO;
ALLERGIC ASTHMA;
ALLERGIC RHINITIS;
ANAPHYLAXIS;
DENDRITIC CELL;
DISEASE SEVERITY;
DOUBLE BLIND PROCEDURE;
ECZEMA;
EDEMA;
EPICUTANEOUS IMMUNOTHERAPY;
ERYTHEMA;
FOLLOW UP;
HUMAN;
IMMUNOGLOBULIN BLOOD LEVEL;
IMMUNOTHERAPY;
LETTER;
NONHUMAN;
NOSE OBSTRUCTION;
OCULAR PRURITUS;
PATIENT COMPLIANCE;
PEAK EXPIRATORY FLOW;
PEANUT ALLERGY;
PHASE 1 CLINICAL TRIAL (TOPIC);
PHASE 2 CLINICAL TRIAL (TOPIC);
PRIORITY JOURNAL;
PRURITUS;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
THROAT IRRITATION;
TRANSDERMAL PATCH;
URTICARIA;
VOMITING;
ADOLESCENT;
ADULT;
ADVERSE EFFECTS;
CHILD;
CLINICAL TRIAL;
CONTROLLED STUDY;
DESENSITIZATION;
DEVICES;
FEMALE;
INTRADERMAL DRUG ADMINISTRATION;
MALE;
MIDDLE AGED;
MULTICENTER STUDY;
PEANUT HYPERSENSITIVITY;
PHASE 1 CLINICAL TRIAL;
PROCEDURES;
RANDOMIZED CONTROLLED TRIAL;
TREATMENT OUTCOME;
YOUNG ADULT;
ADMINISTRATION, CUTANEOUS;
ADOLESCENT;
ADULT;
CHILD;
DESENSITIZATION, IMMUNOLOGIC;
DOUBLE-BLIND METHOD;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
MALE;
MIDDLE AGED;
PATIENT COMPLIANCE;
PEANUT HYPERSENSITIVITY;
TREATMENT OUTCOME;
YOUNG ADULT;
|
|
EID: 84959148944
PISSN: 00916749
EISSN: 10976825
Source Type: Journal
DOI: 10.1016/j.jaci.2016.01.008 Document Type: Article |
|
Times cited : (79)
|
|
References (10)
|
